Global Glass Manufacturer To Build $371M Plant, Create 400 Jobs In Wilson

SCHOTT Pharma USA, Inc., a subsidiary of the global specialty glass manufacturer, SCHOTT Pharma AG, plans to invest $371 million to build a new production facility in Wilson, North Carolina over the next five years. This facility would create 401 jobs and produce glass pre-fillable syringes and cartridges for biopharma companies. This will be SCHOTT Pharma's first facility in the US to manufacture high-performance, pre-fillable polymer syringes, adding to the nation's limited supply of these syringes. The facility is expected to be operational in three years. Continue reading to learn more about this project and its impact on both the state of North Carolina as well as the pharmaceutical supply chain.